Drug Shortage Report for TEVA-MONTELUKAST
| Report ID | 273302 |
| Drug Identification Number | 02355515 |
| Brand name | TEVA-MONTELUKAST |
| Common or Proper name | MONTELUKAST 5MG CHEW TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MONTELUKAST |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET (CHEWABLE) |
| Route of administration | ORAL ORAL |
| Packaging size | PP 30 |
| ATC code | R03DC |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-12-03 |
| Estimated end date | 2026-02-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-04 | French | Compare |
| v1 | 2025-12-04 | English | Compare |
Showing 1 to 2 of 2